{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:39:31Z","timestamp":1759401571457},"reference-count":54,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.vaccine.2008.05.083","type":"journal-article","created":{"date-parts":[[2008,6,18]],"date-time":"2008-06-18T08:43:59Z","timestamp":1213778639000},"page":"4557-4562","source":"Crossref","is-referenced-by-count":13,"title":["Neonatal immune response and serum bactericidal activity induced by a meningococcal conjugate vaccine is enhanced by LT-K63 and CpG2006"],"prefix":"10.1016","volume":"26","author":[{"given":"Siggeir F.","family":"Brynjolfsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania P.","family":"Bjarnarson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Del Giudice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingileif","family":"Jonsdottir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25\u201326","key":"10.1016\/j.vaccine.2008.05.083_bib1","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1016\/S0264-410X(01)00028-7","article-title":"Neonatal and early life vaccinology","volume":"19","author":"Siegrist","year":"2001","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2008.05.083_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/jcp.56.6.417","article-title":"The immunopathogenesis of meningococcal disease","volume":"56","author":"Kvalsvig","year":"2003","journal-title":"J Clin Pathol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.05.083_bib3","first-page":"281","article-title":"Epidemics of meningococcal disease, African meningitis belt","year":"2001","journal-title":"Weekly Epidemiologic Rec"},{"issue":"12 Suppl","key":"10.1016\/j.vaccine.2008.05.083_bib4","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1097\/01.inf.0000147642.85129.05","article-title":"Global epidemiology of meningococcal disease and vaccine efficacy","volume":"23","author":"Pollard","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2008.05.083_bib5","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1542\/peds.60.5.730","article-title":"Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland","volume":"60","author":"Peltola","year":"1977","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.vaccine.2008.05.083_bib6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00006454-199605000-00009","article-title":"Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines","volume":"15","author":"Steinhoff","year":"1996","journal-title":"Pediatr Infect Dis J"},{"issue":"14","key":"10.1016\/j.vaccine.2008.05.083_bib7","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/jama.276.14.1181","article-title":"Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b","volume":"276","author":"Robbins","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2008.05.083_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-1-4899-1382-1_22","article-title":"Hypothesis: how licensed vaccines confer protective immunity","volume":"397","author":"Robbins","year":"1996","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.05.083_bib9","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1128\/IAI.70.3.1443-1452.2002","article-title":"Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a non toxic mutant of heat-labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice","volume":"70","author":"Jakobsen","year":"2002","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.083_bib10","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/eji.200425850","article-title":"The advantage of mucosal immunization for polysaccharide-specific memory responses in early life","volume":"35","author":"Bjarnarson","year":"2005","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.05.083_bib11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-3083.2007.01970.x","article-title":"Effects of LT-K63 and CpG2006 on phenotype and function of murine neonatal lymphoid cells","volume":"66","author":"Olafsdottir","year":"2007","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2008.05.083_bib12","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/infdis\/173.3.627","article-title":"Mechanisms for mucosal immunogenicity and adjuvanticity of Escherichia coli labile enterotoxin","volume":"173","author":"Takahashi","year":"1996","journal-title":"J Infect Dis"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2008.05.083_bib13","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0264-410X(98)80100-X","article-title":"Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli","volume":"16","author":"Douce","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.05.083_bib14","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.4049\/jimmunol.165.10.5750","article-title":"Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity","volume":"165","author":"Ryan","year":"2000","journal-title":"J Immunol"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2008.05.083_bib15","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/S0264-410X(00)00553-3","article-title":"Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants","volume":"19","author":"Pizza","year":"2001","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2008.05.083_bib16","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1086\/320202","article-title":"Characterization of the antibody response to pneumococcal glycoconjugates and the effect of heat-labile enterotoxin on IgG subclasses after intranasal immunization","volume":"183","author":"Jakobsen","year":"2001","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.083_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/14760584.2.2.285","article-title":"Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines","volume":"2","author":"Peppoloni","year":"2003","journal-title":"Expert Rev Vaccines"},{"issue":"6522","key":"10.1016\/j.vaccine.2008.05.083_bib18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"issue":"6813","key":"10.1016\/j.vaccine.2008.05.083_bib19","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.vaccine.2008.05.083_bib20","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1073\/pnas.93.7.2879","article-title":"CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma","volume":"93","author":"Klinman","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.083_bib21","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4049\/jimmunol.160.2.870","article-title":"CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen","volume":"160","author":"Davis","year":"1998","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.05.083_bib22","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1128\/IAI.67.11.5892-5897.1999","article-title":"Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections","volume":"67","author":"Jakobsen","year":"1999","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.083_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1365-3083.2003.01292.x","article-title":"Mucosal vaccination against encapsulated respiratory bacteria\u2014new potentials for conjugate vaccines?","volume":"58","author":"Jakobsen","year":"2003","journal-title":"Scand J Immunol"},{"issue":"4 Suppl","key":"10.1016\/j.vaccine.2008.05.083_bib24","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1038\/nm1216","article-title":"Can successful vaccines teach us how to induce efficient protective immune responses?","volume":"11","author":"Lambert","year":"2005","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.083_bib25","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1128\/IAI.73.2.956-964.2005","article-title":"Protective levels of polysaccharide-specific maternal antibodies may enhance the immune response elicited by pneumococcal conjugates in neonatal and infant mice","volume":"73","author":"Richter","year":"2005","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.083_bib26","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/S0264-410X(03)00205-6","article-title":"Vaccination strategies. An overview","volume":"21 Suppl","author":"Del Giudice","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.083_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2958.1994.tb01266.x","article-title":"Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis","volume":"14","author":"Pizza","year":"1994","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2008.05.083_bib28","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.4049\/jimmunol.162.3.1611","article-title":"CpG oligonucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming","volume":"162","author":"Kovarik","year":"1999","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.05.083_bib29","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/JCM.32.6.1475-1482.1994","article-title":"Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay","volume":"32","author":"Gheesling","year":"1994","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.083_bib30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0022-1759(93)90369-I","article-title":"The role of pH in modified ELISA procedures used for the estimation of functional antibody affinity","volume":"166","author":"Goldblatt","year":"1993","journal-title":"J Immunol Methods"},{"issue":"9","key":"10.1016\/j.vaccine.2008.05.083_bib31","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1128\/IAI.70.9.4785-4790.2002","article-title":"Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles","volume":"70","author":"Baudner","year":"2002","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.083_bib32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.05.083_bib33","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.05.083_bib34","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1086\/379375","article-title":"Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity","volume":"188","author":"Welsch","year":"2003","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2008.05.083_bib35","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0264-410X(92)90091-W","article-title":"Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C","volume":"10","author":"Costantino","year":"1992","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.083_bib36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/317646","article-title":"Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers","volume":"183","author":"Richmond","year":"2001","journal-title":"J Infect Dis"},{"issue":"19","key":"10.1016\/j.vaccine.2008.05.083_bib37","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.280.19.1685","article-title":"Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial","volume":"280","author":"MacDonald","year":"1998","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.vaccine.2008.05.083_bib38","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1001\/jama.283.21.2795","article-title":"Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: a randomized controlled trial","volume":"283","author":"MacLennan","year":"2000","journal-title":"JAMA"},{"issue":"9251","key":"10.1016\/j.vaccine.2008.05.083_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(00)03594-7","article-title":"Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England","volume":"357","author":"Ramsay","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.083_bib40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jama.2007.29-c","article-title":"Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial","volume":"299","author":"Snape","year":"2008","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2008.05.083_bib41","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","article-title":"Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story","volume":"20","author":"Miller","year":"2001","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.083_bib42","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4161\/hv.2.2.2611","article-title":"Modeling future changes to the meningococcal serogroup C conjugate (MCC) vaccine program in England and Wales","volume":"2","author":"Trotter","year":"2006","journal-title":"Hum Vaccin"},{"issue":"7385","key":"10.1016\/j.vaccine.2008.05.083_bib43","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis","volume":"326","author":"Ramsay","year":"2003","journal-title":"BMJ"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2008.05.083_bib44","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1016\/S0264-410X(03)00305-0","article-title":"The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines","volume":"21","author":"Baudner","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.05.083_bib45","unstructured":"Baudner BC. Mucosal vaccine delivery. The concominant use of chitosan-based delivery systems and adjuvants for improved efficacy of nasally administered Neisseria meningitis vaccines. PhD thesis, Leiden University; 2005."},{"key":"10.1016\/j.vaccine.2008.05.083_bib46","unstructured":"Adarna BC. Immune responses to novel pneumococcal conjugates and effects of novel adjuvants. MSc thesis, University of Iceland; 2004."},{"key":"10.1016\/j.vaccine.2008.05.083_bib47","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000319350","article-title":"IgG effector mechanisms","volume":"65","author":"Clark","year":"1997","journal-title":"Chem Immunol"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2008.05.083_bib48","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection\u2014serum bactericidal antibody activity","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2008.05.083_bib49","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.4049\/jimmunol.154.8.4195","article-title":"Functional differences in idiotypically defined IgG1 anti-polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type B polysaccharide-protein conjugates","volume":"154","author":"Lucas","year":"1995","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.05.083_bib50","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jama.267.11.1489","article-title":"Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group","volume":"267","author":"Schlesinger","year":"1992","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.vaccine.2008.05.083_bib51","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1128\/IAI.67.5.2366-2370.1999","article-title":"Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides","volume":"67","author":"Usinger","year":"1999","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2008.05.083_bib52","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0952-7915(99)80029-6","article-title":"B cell memory and the long-lived plasma cell","volume":"11","author":"McHeyzer-Williams","year":"1999","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.05.083_bib53","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1574-695X.2000.tb01460.x","article-title":"Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titres in children following vaccination with a meningococcal A\/C polysaccharide vaccine","volume":"28","author":"Borrow","year":"2000","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2008.05.083_bib54","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0264-410X(99)00276-5","article-title":"Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults","volume":"18","author":"Richmond","year":"1999","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08007093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08007093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:56:18Z","timestamp":1684443378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08007093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":54,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0264410X08007093"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.05.083","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}